Discovery of N-(2-chloro-6-methyl- phenyl)-2-(6-(4-(2-hydroxyethyl)- piperazin-1-yl)-2-methylpyrimidin-4- ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src/Abl kinase inhibitor with potent antitumor activity in preclinical assays. (Q45198729)
scientific article published in December 2004
Language:
(P31) (Q13442814)
(P50) (Q67487747)
(P304) 6658-6661
(P407) (Q1860)
(P433) 27
(P478) 47
(P577) Wednesday, December 1, 2004
(P921) (Q419940)
(P1433) (Q900316)
(P1476) "Discovery of N-(2-chloro-6-methyl- phenyl)-2-(6-(4-(2-hydroxyethyl)- piperazin-1-yl)-2-methylpyrimidin-4- ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src/Abl kinase inhibitor with potent antitumor activity in preclinical assays" (language: en)
(P2093) Louis J Lombardo
Francis Y Lee
Ping Chen
Derek Norris
Joel C Barrish
Kamelia Behnia
Stephen Castaneda
Lyndon A M Cornelius
Jagabandhu Das
Arthur M Doweyko
Craig Fairchild
Ivan Inigo
Kathy Johnston
Amrita Kamath
David Kan
Herbert Klei
Punit Marathe
Suhong Pang
Russell Peterson
Sidney Pitt
Gary L Schieven
Robert J Schmidt
John Tokarski
Mei-Li Wen
John Wityak
Robert M Borzilleri
other details
description scientific article published in December 2004

External Links